A single monoclonal antibody isolated from a human survivor of Ebola virus disease (EVD) completely protected monkeys from lethal infection with the virus, according to research published in today's online edition of the ...
Feb 25, 2016
0
2
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues have discovered that a single monoclonal antibody—a protein that attacks viruses—isolated ...
Feb 25, 2016
0
47
A tiny study suggests that the experimental Ebola treatment ZMapp sharply increases the chance of surviving the deadly virus.
Feb 24, 2016
0
0
Two investigational vaccines designed to protect against Ebola virus disease were well-tolerated and induced an immune response among 1,000 vaccinated participants in the Phase 2 randomized, placebo-controlled clinical trial ...
Feb 24, 2016
0
0
Preliminary findings from PREVAIL III, a study of Ebola virus disease (EVD) survivors being conducted in Liberia, indicate that both Ebola survivors and their close contacts have a high burden of illness. However, the prevalence ...
Feb 24, 2016
0
0
According to initial results from a randomized, controlled trial of the experimental Ebola treatment ZMapp, the monoclonal antibody cocktail was well-tolerated and showed promise. Due to decreasing incidence in Ebola, the ...
Feb 24, 2016
0
0
There may be a "silver bullet" for Ebola, a family of hemorrhagic viruses, one of which has killed more than 11,000 people in West Africa in the past two years.
Jan 21, 2016
0
41
A new probable case of Ebola in Sierra Leone highlights the continued risk in west Africa, the World Health Organization said Friday, a day after the end of the deadliest outbreak in history was announced.
Jan 15, 2016
0
2
The world breathed a sigh of relief Thursday as a two-year Ebola epidemic that killed 11,000 and triggered a global health alert was declared over, with Liberia the last country to get the all-clear.
Jan 14, 2016
0
0
As doctors struggled to treat growing numbers of patients during the Ebola crisis in West Africa, the shortage of one helpful drug may have led to the discovery of a better one.
Jan 6, 2016
0
25
